Stock Trend Analysis Report
Prepared for you on Tuesday, November 28, 2023.
Range Cancer Therapeutics ETF (NASDAQ:CNCR)
Sidelines Mode (-55) - CNCR is moving in a sideways pattern and is unable to gain momentum in either direction. Beware of choppy movement and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for CNCR
The long-term trend has been DOWN since Aug 7th, 2023 at 12.3300
The intermediate-term trend has been UP since Nov 15th, 2023 at 10.7000
The short-term trend has been DOWN since Nov 22nd, 2023 at 10.4601
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a -55 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||32.32||Year High Date||2018-03-13|
|Year Low||19.1252||Year Low Date||2018-10-29|
|52wk High||15.2799||52wk High Date||2022-12-14|
|52wk Low||9.22||52wk Low Date||2023-10-27|
|Average Volume||1,724||Shares Outstanding||100|